CAPE is one of four consortia (PAINSTORM, CRIISP, ALLEVIATE) funded as part of the Advanced Pain Discovery Platform (APDP) initiative. APDP is led by Professor David Walsh.
The consortium is funded by UK Research and Innovation, Versus Arthritis and Eli Lilly.
